miR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2

Author： Chen Xiong Zhang Yingying Shi Yingying Lian Haiwei Tu Huilin Han Song Peng Biwen Liu Wanhong He Xiaohua

E-ISSN： 1791-2423|47|4|1603-1611

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.47, Iss.4, 2015-10, pp. : 1603-1611

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

miR-203 sensitizes glioma cells to temozolomide and inhibits glioma cell invasion by targeting E2F3

Molecular Medicine Reports, Vol. 11, Iss. 4, 2015-01 ,pp. : 2838-2844

Spandidos Publications

Access to resources Recommend Favorite

miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy

By Yin Wenjun Nie Yuehua Zhang Zhiwei Xie Liming He Xiusheng

Oncology Reports, Vol. 34, Iss. 1, 2015-07 ,pp. : 368-374

Spandidos Publications

Access to resources Recommend Favorite

Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2

By Fan Bo Jiao Bao-Hua Fan Feng-Shi Lu Sheng-Kui Song Jian Guo Cheng-Yong Yang Jian-Kai Yang Liang

International Journal of Oncology, Vol. 47, Iss. 3, 2015-09 ,pp. : 1025-1033

Spandidos Publications

Access to resources Recommend Favorite

Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells

By Yang Jie

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1114-1118

Humana Press, Inc

Access to resources Recommend Favorite

miR-1271 Regulates Cisplatin Resistance of Human Gastric Cancer Cell Lines by Targeting IGF1R, IRS1, mTOR, and BCL2

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 6, 2014-07 ,pp. : 884-891

Bentham Science Publishers

Access to resources Recommend Favorite